Related Posts
Gold and Alternative Investments Conference 2019
30 Sep 2019 - Symposium, Managing Director, Kerry Stevenson talks about the importance of gold in a diversified portfolio, its successful performance over the past 12 months and all that’s on offer at this year’s event, 24-26 October, Sydney Sofitel Wentworth.
Read MoreTechnology giant Macnica takes strategic investment in icetana (ASX:ICE)
12 Oct 2022 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses revenue growth, the company's strategic placement to Macnica, changes to the share registry and the outlook ahead.
Read MoreIs this the start of more M&A activity?
24 Jan 2024 - Investment expert Winston Sammut discusses recent M&A activity in the property sector, analyzing BWP Trust's bid for Newmarket and Aspen's offer for Eureka Holdings. Sammut shares insights on deal rationale, pricing concerns, and potential market implications.
Read MoreFirst Graphene (ASX:FGR) completes capital raising
09 Jun 2020 - First Graphene Limited (ASX:FGR) Non-Executive Chairman Warwick Grigor talks about graphene-enhanced products, the company's capital raising and its focus on the mining industry.
Read MoreLake Resources (ASX:LKE) announces two-phase production strategy for battery-grade lithium carbonate
22 Jun 2023 - Lake Resources Limited (ASX:LKE) Managing Director David Dickson discusses the company's two-phase strategy.
Read MoreCashwerkz (ASX:CWZ) 1H20 results & outlook
26 Mar 2020 - Cashwerkz Limited (ASX:CWZ) Executive Chairman John Nantes talks about the company's 1H20 results, new partners to the platform, outlook for the second half and impact of COVID-19.
Read MoreExtending the lives of patients with brain cancer
25 Oct 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses efficacy results for the company's glioblastoma therapy.
Read MoreMarket update with Shaw and Partners, May 2022
25 May 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the paradox of rising valuations in a looming bear market.
Read MoreIVE Group (ASX:IGL) positioned for growth
07 Sep 2022 - IVE Group (ASX:IGL) Executive Chairman Geoff Selig discusses full-year results, the recent acquisition of Ovato and the launch of the Lasoo e-commerce platform.
Read MoreOpthea (ASX:OPT) combatting macular degeneration
10 Mar 2020 - Opthea Limited (ASX:OPT) Managing Director and CEO, Dr Megan Baldwin talks about results from the company's lead drug candidate OPT-302, and new funding for further clinical development for wet AMD (age-related macular degeneration) and DME (diabetic macular degeneration).
Read More